Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug utilization in the Maastricht Study: A comparison with nationwide data.

Medicine·2020
Same author

Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.

Diabetes technology & therapeutics·2019
Same author

Corrigendum to: Cohort Profile: The Hoorn Studies.

International journal of epidemiology·2019
Same author

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.

BMJ open diabetes research & care·2019
Same author

High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.

Journal of clinical lipidology·2019
Same author

Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.

Hypertension (Dallas, Tex. : 1979)·2019

Related Experiment Video

Updated: May 28, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Heart failure and cognitive function in the general population: the Hoorn Study.

Katja van den Hurk1, Yael D Reijmer, Esther van den Berg

  • 1Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, Amsterdam, The Netherlands.

European Journal of Heart Failure
|October 13, 2011
PubMed
Summary

Reduced cognitive functioning, including attention and executive skills, is linked to early stages of left ventricular (LV) dysfunction and heart failure. Brain natriuretic peptide (BNP) may be a key indicator for cognitive decline.

Related Experiment Videos

Last Updated: May 28, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Area of Science:

  • Cardiology
  • Neuroscience
  • Gerontology

Background:

  • Cardiovascular diseases, including heart failure, are increasingly prevalent in aging populations.
  • Cognitive decline is a significant concern in older adults, impacting quality of life.
  • The relationship between early cardiac dysfunction and cognitive impairment requires further elucidation.

Purpose of the Study:

  • To investigate the association between early left ventricular (LV) dysfunction and cognitive functioning.
  • To determine if markers of cardiac health predict cognitive performance in older adults.
  • To explore the role of brain natriuretic peptide (BNP) in cognitive decline.

Main Methods:

  • Longitudinal study of 313 non-demented older adults (59-87 years) from the Hoorn Study.
  • Echocardiography assessed LV systolic and diastolic function at baseline and follow-up.
  • Cognitive tests evaluated information processing speed, memory, attention, and executive functioning; BNP levels were measured.

Main Results:

  • Baseline LV diastolic function, not systolic function, correlated with lower attention and executive functioning scores at follow-up.
  • Elevated baseline and follow-up brain natriuretic peptide (BNP) levels were associated with poorer performance across all cognitive domains.
  • Individuals with heart failure at follow-up exhibited significantly lower attention and executive functioning scores.

Conclusions:

  • Early-stage left ventricular dysfunction and heart failure are associated with measurable deficits in cognitive functioning.
  • Brain natriuretic peptide (BNP) emerges as a potential biomarker and risk factor for cognitive decline in the general population.
  • These findings highlight the interconnectedness of cardiovascular and cognitive health in aging individuals.